Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 55, 2020 - Issue 4
Submit an article Journal homepage
198
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Risk factors for short recurrence-free survival after resection of pancreatic neuroendocrine tumor (PanNET) liver metastases: which patients should undergo resection?

Toshihiko MasuiDepartment of Surgery, Kyoto University, Kyoto, JapanCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-4001-4824View further author information
ORCID Icon,
Kazuyuki NagaiDepartment of Surgery, Kyoto University, Kyoto, JapanView further author information
,
Takayuki AnazawaDepartment of Surgery, Kyoto University, Kyoto, JapanView further author information
,
Yosuke KasaiDepartment of Surgery, Kyoto University, Kyoto, JapanView further author information
,
Asahi SatoDepartment of Surgery, Kyoto University, Kyoto, JapanView further author information
,
Kenzo NakanoDepartment of Surgery, Kyoto University, Kyoto, JapanView further author information
,
Yuichiro UchidaDepartment of Surgery, Kyoto University, Kyoto, JapanView further author information
,
Akitada YogoDepartment of Surgery, Kyoto University, Kyoto, JapanView further author information
,
Yoshiya KawaguchiDepartment of Surgery, Kyoto University, Kyoto, JapanView further author information
,
Kyoichi TakaoriDepartment of Surgery, Kyoto University, Kyoto, JapanView further author information
&
Shinji UemotoDepartment of Surgery, Kyoto University, Kyoto, JapanView further author information
 show all
Pages 479-484 | Received 22 Dec 2019, Accepted 11 Mar 2020, Published online: 30 Mar 2020

References

  • Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–1342.
  • Hallet J, Law CH, Cukier M, et al. Exploring the rising incidence of neuroendocrine tumors: A population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer. 2015;121(4):589–597.
  • Tsai HJ, Wu CC, Tsai CR, et al. The epidemiology of neuroendocrine tumors in taiwan: A nation-wide cancer registry-based study. PLoS One. 2013;8(4):e62487.
  • Ito T, Sasano H, Tanaka M, et al. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in japan. J Gastroenterol. 2010;45(2):234–243.
  • Martin-Perez E, Capdevila J, Castellano D, et al. Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. The large experience of the spanish national tumor registry (rgetne). Neuroendocrinology. 2013;98(2):156–168.
  • Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. JCO. 2008;26(18):3063–3072.
  • Pavel M, O’Toole D, Costa F; Vienna Consensus Conference participants, et al. ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (nen) and nen of unknown primary site. Neuroendocrinology. 2016;103(2):172–185.
  • National Comprehensive Cancer N: Nccn clinical practice guidelines in oncology. 2019. Available from: http://wwwnccnorg/professionals/physician_gls/PDF/sclcpdf.
  • Gurusamy KS, Ramamoorthy R, Sharma D, et al. Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastases. Cochrane Database Syst Rev. 2009;(2):CD007060.
  • Saxena A, Chua TC, Sarkar A, et al. Progression and survival results after radical hepatic metastasectomy of indolent advanced neuroendocrine neoplasms (nens) supports an aggressive surgical approach. Surgery. 2011;149(2):209–220.
  • Scigliano S, Lebtahi R, Maire F, et al. Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience. Endocr Relat Cancer. 2009;16(3):977–990.
  • Ito T, Hijioka S, Masui T, et al. Advances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in japan. J Gastroenterol. 2017;52(1):9–18.
  • Lee L, Igarashi H, Fujimori N, et al. Long-term outcomes and prognostic factors in 78 japanese patients with advanced pancreatic neuroendocrine neoplasms: a single-center retrospective study. Jpn J Clin Oncol. 2015;45(12):1131–1138.
  • Woltering EA, Voros BA, Beyer DT, et al. Aggressive surgical approach to the management of neuroendocrine tumors: a report of 1,000 surgical cytoreductions by a single institution. J Am Coll Surg. 2017;224(4):434–447.
  • Scott AT, Breheny PJ, Keck KJ, et al. Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (netlms). Surgery. 2019;165(1):166–175.
  • Capurso G, Rinzivillo M, Bettini R, et al. Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. Br J Surg. 2012;99(11):1480–1486.
  • Elias D, Lasser P, Ducreux M, et al. Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study. Surgery. 2003;133(4):375–382.
  • Yao KA, Talamonti MS, Nemcek A, et al. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery. 2001;130(4):677–682. discussion 682–675.
  • Kasai Y, Hirose K, Corvera CU, et al. Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis. J Surg Oncol. 2019. DOI:10.1002/jso.25811
  • Spolverato G, Bagante F, Aldrighetti L, et al. Neuroendocrine liver metastasis: Prognostic implications of primary tumor site on patients undergoing curative intent liver surgery. J Gastrointest Surg. 2017;21(12):2039–2047.
  • Keck KJ, Choi A, Maxwell JE, Li G, et al. Increased grade in neuroendocrine tumor metastases negatively impacts survival. Ann Surg Oncol. 2017;24(8):2206–2212.
  • Elias D, Lefevre JH, Duvillard P, et al. Hepatic metastases from neuroendocrine tumors with a “thin slice” pathological examination: they are many more than you think. Ann Surg. 2010;251(2):307–310.
  • Gibson WE, Gonzalez RS, Cates JMM, et al. Hepatic micrometastases are associated with poor prognosis in patients with liver metastases from neuroendocrine tumors of the digestive tract. Hum Pathol. 2018;79:109–115.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.